Tag: generic drugs
International Perspectives on NTI Generics: Regulatory Approaches Compared
NTI generics require strict regulatory oversight due to their narrow safety margin. This article compares how the FDA, EMA, Health Canada, and others regulate these high-risk drugs, highlighting differences in bioequivalence standards, approval timelines, and substitution rules.
Dec 19 2025
How Insurers Decide Which Generic Drugs to Cover
Insurers use Pharmacy & Therapeutics committees to decide which generic drugs to cover, prioritizing safety, effectiveness, and cost. Most generics are placed in the lowest-cost tier, but coverage varies by plan - and patients can appeal denials.
Dec 15 2025
Common Pharmacist Concerns About Generic Substitution: What Really Happens Behind the Counter
Pharmacists support generic substitution for cost savings, but face resistance from patients and doctors. Learn why trust, communication, and NTI drugs create real-world challenges behind the pharmacy counter.
Dec 8 2025
Therapeutic Equivalence Codes: How the FDA Determines If Generic Drugs Can Be Substituted
Therapeutic equivalence codes tell you if a generic drug can be safely swapped for a brand-name version. The FDA uses the Orange Book to assign A or B ratings based on bioequivalence, helping pharmacists make safe substitutions that save billions each year.
Nov 22 2025
Generic Manufacturing Standards: How Quality Control Stops Counterfeit Drugs
Generic drugs are just as safe as brand-name ones - if they’re made under strict quality control. Learn how cGMP standards, digital tracking, and advanced testing stop counterfeit drugs before they reach patients.
Nov 10 2025
![Sartel (Telmisartan) Uses, Dosage, Side Effects, Interactions [2025 Guide]](/uploads/2025/08/thumbnail-sartel-telmisartan-uses-dosage-side-effects-interactions-2025-guide.webp)
